Skip to navigation | Skip to main content | Skip to footer
Menu Search the University of Manchester siteSearch
Search type

Alternatively, use our A–Z index

Dr Eleanor Cheadle (PhD) - personal details

Contact details

Role: Postdoctoral Research Fellow

Tel: +44 (0)161 918 7006


Institute of Cancer Sciences
The University of Manchester
Wilmslow Road
M20 4BX

Fax: + 44 (0) 161 446 3268




I undertook my PhD at the University of Leeds from 1999-2002 studing recombinant mycobacterial cancer vaccines and their interaction with dendritic cells and lymphocytes under the supervision of Dr Andrew Jackson and Professor Peter Selby. I then moved to the University of Manchester in 2002 where I began work as a postdoctoral research associate in the group of Professor Robert Hawkins and Dr David Gilham. My work focused on the generation and testing of chimeric antigen receptor (CAR) T-cells targeting CD19 for use in the treatment of B-cell malignancies. This work led to an ongoing Kay Kendall Leukaemia funded Phase I clinical trial testing CD19 CAR T-cells in B-cell lymphoma. In 2009 I joined the Targeted Therapy group led by Professor Tim Illidge and my research has focused on investigating the mechanisms of action of type I and type II anti-CD20 antibodies and improving their efficacy in B-cell malignancies through the use of immunomodulatory agents to enhance adaptive immune responses.

Memberships of Committees and Professional Bodies

British Society for Immunology


PhD (University of Leeds), B.Sc (Hons) (University of Birmingham)


MRes Oncology Tutorials